YOLFTbeta
MEDIGENE N (MDG1.SG)

MEDIGENE N (MDG1.SG)

MDG1 · STU · Other / Other

2.04EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close2.04
Open2.04
Day Range2.04 – 2.04
52-Week Range2.04 – 2.04
Volume0
Market Cap76.02M
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg2.04
200-Day Avg2.04

About

There is no Profile data available for MDG1.SG.

Company Details

  • SectorOther
  • IndustryOther
  • Employees0
  • HeadquartersGermany

Financials

Income Statement

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Revenue4.89M7.80M7.58M10.51M8.00M10.46M31.25M6.03M
Growth (%)-+59.52%-2.90%+38.74%-23.87%+30.75%+198.64%-80.69%
Cost of Revenue1.40M1.62M6.30M383.00K1.29M1.36M1.98M1.64M
Gross Profit3.49M6.18M1.28M10.13M6.71M9.10M29.26M4.39M
Gross Margin71.34%79.22%16.84%96.36%83.85%87.00%93.65%72.77%
Operating Expense19.07M20.65M19.10M30.29M30.04M19.09M37.99M20.54M
Operating Income-15.58M-14.47M-17.82M-20.16M-23.33M-9.98M-8.73M-16.15M
Operating Margin-318.56%-185.45%-235.28%-191.81%-291.59%-95.43%-27.93%-267.63%
EBITDA--10.54M-15.29M-17.10M-21.50M-6.49M13.14M-14.58M
EBITDA Margin--135.07%-201.77%-162.65%-268.72%-62.04%42.04%-241.65%
Net Income-9.49M-13.57M-17.05M-19.96M-28.88M-9.98M-8.33M-16.18M
Net Income Margin-194.07%-173.97%-225.04%-189.92%-360.85%-95.41%-26.66%-268.10%
R&D11.54M14.88M1.76M22.62M22.26M12.80M28.50M11.54M
R&D as % of Total Revenue235.90%190.68%23.26%215.22%278.21%122.31%91.21%191.33%
Interest Expense00146.00K450.00K428.00K364.00K659.00K548.00K
Interest Expense % of Total Revenue0.00%0.00%1.93%4.28%5.35%3.48%2.11%9.08%

Balance Sheet

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Total Assets111.72M111.94M129.59M109.22M74.75M59.47M51.68M31.72M
Total Liabilities33.12M25.77M22.16M27.39M21.60M14.65M14.65M10.65M
Total Equity78.59M86.17M107.42M81.82M53.15M44.82M37.03M21.07M
Cash14.63M27.72M27.41M34.68M30.03M22.42M22.22M8.67M

Cash Flow

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Cash Flow-3.76M-20.85M-10.14M-16.42M-24.79M-10.75M11.98M-15.12M
Capital Expenditure1.72M1.56M1.01M1.43M484.00K125.00K1.01M664.00K
Free Cash Flow--22.41M-11.16M-17.85M-25.27M-10.88M10.97M-15.78M
FCF to OCF-107.50%110.00%108.70%101.95%101.16%91.59%104.39%

Earnings

Report DateAug 17, 2023
EPS Estimate-0.81
EPS Actual-0.17
Surprise79.01%
TimingAfter-hours

Key Statistics & Ratios

Market Cap76.02M
Enterprise Value94.32K
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales3.63
Price / Book1.53
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding0
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 29, 20241:2
  • Sep 3, 20131:4